The Hybrid Coronary Approach for Optimal Revascularization: JACC Review Topic of the Week

Highlights •HCR combines reduced invasiveness of PCI, with a LIMA to the LAD. •The off-pump, minimally invasive CABG reduces cardiovascular accident, bleeding, infection, mechanical ventilation, and length of stay. •The National Heart, Lung, and Blood Institute–sponsored Hybrid Trial, which randomized PCI versus HCR, was stopped prematurely for lack of enrollment. •Powered randomized trials are needed to evaluate cost-effectiveness of HCR versus CABG or multivessel PCI.